TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers
- PMID: 15958551
- DOI: 10.1158/0008-5472.CAN-05-0551
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers
Abstract
TP53 mutations are common in lung cancers of smokers, with high prevalence of G:C-to-T:A transversions generally interpreted as mutagen fingerprints of tobacco smoke. In this study, TP53 (exons 5-9) and KRAS (codon 12) were analyzed in primary lung tumors of never (n = 40), former (n = 27), and current smokers (n = 64; mainly heavy smokers). Expression of p53, cyclooxygenase-2 (Cox-2), and nitrotyrosine (N-Tyr), a marker of protein damage by nitric oxide, were analyzed by immunohistochemistry. TP53 mutations were detected in 47.5% never, 55.6% former, and 77.4% current smokers. The relative risk for mutation increased with tobacco consumption (P(linear trend) < 0.0001). G:C-to-T:A transversions (P = 0.06, current versus never smokers) and A:T-to-G:C transitions (P = 0.03, former versus never smokers) were consistently associated with smoking. In contrast, G:C-to-A:T transitions were associated with never smoking (P = 0.02). About half of mutations in current smokers fell within a particular domain of p53 protein, suggesting a common structural effect. KRAS mutations, detected in 20 of 131 (15.3%) cases, were rare in squamous cell carcinoma compared with adenocarcinoma [relative risk (RR), 0.2; 95% confidence interval (95% CI), 0.07-1] and were more frequent in former smokers than in other categories. No significant differences in Cox-2 expression were found between ever and never smokers. However, high levels of N-Tyr were more common in never than ever smokers (RR, 10; 95% CI, 1.6-50). These results support the notion that lung tumorigenesis proceeds through different molecular mechanisms according to smoking status. In never smokers, accumulation of N-Tyr suggests an etiology involving severe inflammation.
Similar articles
-
p53 and K-ras mutations in lung cancers from former and never-smoking women.Cancer Res. 2001 Jun 1;61(11):4350-6. Cancer Res. 2001. PMID: 11389059
-
p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.Cancer Res. 2000 Jun 1;60(11):2906-11. Cancer Res. 2000. PMID: 10850436
-
Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10207632
-
The TP53 gene, tobacco exposure, and lung cancer.Hum Mutat. 2003 Mar;21(3):229-39. doi: 10.1002/humu.10177. Hum Mutat. 2003. PMID: 12619108 Review.
-
Lung cancer in never smokers: a review.J Clin Oncol. 2007 Feb 10;25(5):561-70. doi: 10.1200/JCO.2006.06.8015. J Clin Oncol. 2007. PMID: 17290066 Review.
Cited by
-
KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways.Cells. 2024 Jul 19;13(14):1221. doi: 10.3390/cells13141221. Cells. 2024. PMID: 39056802 Free PMC article. Review.
-
Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.Cancer Med. 2024 May;13(10):e7227. doi: 10.1002/cam4.7227. Cancer Med. 2024. PMID: 38770632 Free PMC article.
-
A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241249168. doi: 10.1177/17534666241249168. Ther Adv Respir Dis. 2024. PMID: 38757628 Free PMC article.
-
Lung Cancer in Never Smokers: Delving into Epidemiology, Genomic and Immune Landscape, Prognosis, Treatment, and Screening.Lung. 2023 Dec;201(6):521-529. doi: 10.1007/s00408-023-00661-3. Epub 2023 Nov 16. Lung. 2023. PMID: 37973682 Review.
-
A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers.Int J Mol Sci. 2023 Aug 28;24(17):13314. doi: 10.3390/ijms241713314. Int J Mol Sci. 2023. PMID: 37686122 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous